Healio

AGA urges antiviral prophylaxis for patients at high risk for hepatitis B reactivation

Please provide your email address to receive an email when new articles are posted on . AGA guidance strongly recommends antiviral prophylaxis for patients at high risk for hepatitis B reactivation.
Healio

Resuming antiviral therapy after withdrawal does not affect HBsAG seroclearance in HBV

Please provide your email address to receive an email when new articles are posted on . Adjusted analysis demonstrated no association between nucleos(t)ide analogue retreatment and HBsAg seroclearance ...
Medscape

HBV Reactivation Risk Low After Tenofovir Cessation in HIV

PARIS — People with HIV and resolved HBV infection who switched from tenofovir-based antiretroviral therapy (ART) to tenofovir-sparing regimens did not see clinically meaningful hepatitis B virus (HBV ...
Monthly Prescribing Reference

ACIP Votes to End Routine Hep B Birth Dose Recommendation

The ACIP voted to recommend that the hepatitis B birth dose be optional for infants of HBsAg-negative mothers, a move strongly opposed by the American Academy of Pediatrics. The Centers for Disease ...